Evidence map›Paper›PMID 28594412›Full record

ArticleEuropean journal of human genetics : EJHG2017

Attitudes, knowledge and consequences of uncertain genetic findings in hypertrophic cardiomyopathy.

Charlotte Burns, Laura Yeates, Catherine Spinks, Christopher Semsarian, Jodie Ingles

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. A Person-Centered Approach to Cardiovascular Genetic Testing.Cold Spring Harbor perspectives in medicine · 2020
    Review
  16. Review
  17. Psychological adaptation to molecular autopsy findings following sudden cardiac death in the young.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Charlotte BurnsAgnes Ginges Centre for Molecular Cardiology, Centenary Institute, Sydney, Australia.
Laura YeatesAgnes Ginges Centre for Molecular Cardiology, Centenary Institute, Sydney, Australia.
Catherine SpinksAgnes Ginges Centre for Molecular Cardiology, Centenary Institute, Sydney, Australia.
Christopher SemsarianAgnes Ginges Centre for Molecular Cardiology, Centenary Institute, Sydney, Australia.
Jodie InglesAgnes Ginges Centre for Molecular Cardiology, Centenary Institute, Sydney, Australia.ORCID 0000-0002-4846-7676

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the surge of next-generation sequencing (NGS) technologies making almost all genetic tests more affordable and available, cardiac genetic testing now routinely encompasses a large number of genes within a panel setting. The additional sensitivity of this practice is limited and has the potential to inflict a spectrum of uncertainty. We sought to explore attitudes, preferences, recall and psychological consequences of informative and uninformative genetic results amongst probands diagnosed with hypertrophic cardiomyopathy (HCM). We conducted semi-structured interviews and analysed the qualitative data using a framework analysis process. In general, we found probands were more concerned with their clinical diagnosis than gene result and in some, recall and understanding of genetic diagnosis was poor. Several participants expected genetic testing would alleviate uncertainty, often holding an altruistic view of participation in testing, removing their sense of self and failing to appreciate fully the familial implications. With the key utility of HCM genetic testing and counselling being for greater risk prediction for at-risk relatives, effective communication within the family is critical. While communication appeared adequate, further questioning found it was often vague, failing to translate into meaningful action by relatives. Based on these findings, a framework of key outcomes to assist multidisciplinary teams in genetic counselling of probands receiving an HCM gene result was developed.

Indexed as

Health Knowledge, Attitudes, PracticeAdultAgedCardiomyopathy, HypertrophicFemaleGenetic CounselingGenetic TestingHumansMaleMiddle Aged

Identifiers

PMID28594412
PMCPMC5520078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.